AtriCure plans IPO (initial public offering) to raise up to $57.5m
This article was originally published in Clinica
Executive Summary
AtriCure, a West Chester, Ohio company that makes devices for cardiac ablation, has filed a registration statement with the US Securities and Exchange Commission (SEC) for a proposed initial public offering (IPO). The company states a maximum offering price of $57.5m, and plans to list on Nasdaq.